Update Posted News Today

Update Posted at 4:45 a.m. Dec. 2.

The Parklands Best Radio Station with news, weather, sports and more.

Novavax COVID-19 Vaccine (NVX-CoV2373) Description Novavax COVID-19 vaccine (NVX-CoV2373) (Covovax) is a prefusion protein coronavirus vaccine candidate made using Novavax’s proprietary nanoparticle technology, Matrix-M, an adjuvant to enhance immune responses and stimulate high levels of neutralizing antibodies. Novavax Inc.s NVX-CoV2373 vaccine candidate creates an engineered baculovirus containing a gene for a modified SARS-CoV-2 spike protein. The baculovirus then infects a culture ...

COVID-19 Vaccine Janssen Description The Johnson and Johnson Janssen COVID-19 single-shot experimental vaccine leverages Janssens AdVac and PER.C6® technologies. Janssen’s AdVac® vectors are based on a specific type of adenovirus, which has been genetically modified so that it can no longer replicate in humans and cause disease. Adenoviruses are a group of viruses that can cause the common cold. The AdVac® technology works by using an adenovirus as a vector (a carrier) of an anti...

INO-4800 COVID-19 Vaccine Description INO-4800 is a DNA vaccine candidate matched to the novel coronavirus SARS-CoV-2, which causes the COVID-19 disease in humans.  INOVIOs INO-4800 is the only nucleic-acid-based vaccine stable at room temperature for more than a year and does not require frozen transport or for years of storage, which are important factors when implementing mass immunizations to battle the current pandemic, says INOVIO. The INO-4800 vaccine contains the plasmid pGX9501, whi...

NVX-CoV2373 COVID-19 Vaccine Description NVX-CoV2373 is a prefusion protein coronavirus vaccine candidate made using Novavax’s proprietary nanoparticle technology, Matrix-M, an adjuvant to enhance immune responses and stimulate high levels of neutralizing antibodies. Novavax’s patented saponin-based Matrix-M adjuvant has demonstrated a potent and well-tolerated effect by stimulating the entry of antigen-presenting cells into the injection site and enhancing antigen presentation in local ly...